1. Home
  2. UFI vs FLNA Comparison

UFI vs FLNA Comparison

Compare UFI & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

HOLD

Current Price

$6.65

Market Cap

76.4M

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.73

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UFI
FLNA
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
61.8M
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
UFI
FLNA
Price
$6.65
$0.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
76.5K
239.2K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$531,303,000.00
$41,119,000.00
Revenue This Year
$1.39
N/A
Revenue Next Year
$12.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.96
$0.67
52 Week High
$8.47
$2.03

Technical Indicators

Market Signals
Indicator
UFI
FLNA
Relative Strength Index (RSI) 44.12 32.49
Support Level $6.42 N/A
Resistance Level $6.76 $0.99
Average True Range (ATR) 0.27 0.05
MACD -0.09 -0.00
Stochastic Oscillator 14.78 26.53

Price Performance

Historical Comparison
UFI
FLNA

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: